High expression of ETAR/IQGAP1/β-arrestin1 positively correlates with poor prognosis in ovarian carcinoma patients (Chellini et al., 2019), suggesting that the IQGAP1:β-arrestin1 interaction could contribute to ovarian carcinoma. This evidence concerns the gene IQGAP1 and ovarian carcinoma.